TABLE 1.
BRONCHOALVEOLAR LAVAGE CHARACTERISTICS AND/OR THE PRESENCE OF GROUND-GLASS OPACITY AT SCREENING
| BAL− Cohort (n = 40) | BAL+ Cohort (n = 101) | P Value* | |
|---|---|---|---|
| BAL characteristics | |||
| Total cells/μl† | 33.0 ± 31.1 | 27.3 ± 28.5 | 0.3065 |
| BAL volume recovered, ml | 131.6 ± 35.6 | 109.1 ± 41.8 | 0.0032 |
| % PMNs | 1.2 ± 0.7 | 8.4 ± 7.7 | <0.0001 |
| % Eosinophils | 0.5 ± 0.4 | 3.9 ± 4.8 | <0.0001 |
| % Lymphocytes | 4.7 ± 4.1 | 5.1 ± 6.5 | 0.7209 |
| Screening HRCT | |||
| Percent with any GGO | 100 | 84.2 | 0.0060 |
| Percent with any RML GGO | 26.3 | 41.2 | 0.1175 |
Definition of abbreviations: BAL = bronchoalveolar lavage; GGO = ground-glass opacity; HRCT = high-resolution computed tomography; PMNs = polymorphonuclear leukocytes; RML = right middle lobe.
BAL− cohort defined as having less than 3% neutrophils and less than 2% eosinophils; BAL+ cohort defined as having 3% or more of neutrophils and/or 2% or more of eosinophils.
Two-tailed Student's t test or Fisher's exact test.
n = 38 for BAL− and 94 for BAL+ cohorts due to missing data for total cell counts.